Sonoma takes ‘a big bite’ with $120M Regeneron Treg collab, tacking on up to 5 new targets

Fierce Biotech

Regulatory T cell-focused Sonoma Biotherapeutics has been following a slow and steady path ever since bringing in a whopping $265 million in a 2021 fundraising round, one of the largest of the year.